BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 28077735)

  • 1. Tuberculosis mimicking metastases by malignancy in FDG PET/CT.
    Liu B; Dong L; Wang X; Han T; Lin Q; Liu M
    QJM; 2017 Mar; 110(3):173-174. PubMed ID: 28077735
    [No Abstract]   [Full Text] [Related]  

  • 2. 18F-FDG PET/CT in a case of multifocal skeletal tuberculosis without pulmonary disease and potential role for monitoring treatment response.
    Cho YS; Chung DR; Lee EJ; Kim BT; Lee KH
    Clin Nucl Med; 2014 Nov; 39(11):980-3. PubMed ID: 24561689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TB determined: tuberculous osteomyelitis.
    Lebowitz D; Wolter L; Zenklusen C; Chouiter A; Malinverni R
    Am J Med; 2014 Mar; 127(3):198-201. PubMed ID: 24333617
    [No Abstract]   [Full Text] [Related]  

  • 4. Detection of occult bone metastases from head and neck squamous cell carcinoma: impact of positron emission tomography computed tomography with fluorodeoxyglucose F 18.
    Basu D; Siegel BA; McDonald DJ; Nussenbaum B
    Arch Otolaryngol Head Neck Surg; 2007 Aug; 133(8):801-5. PubMed ID: 17709620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDG PET/CT findings in primary hyperparathyroidism mimicking multiple bone metastases.
    Demir H; Halac M; Gorur GD; Sonmezoglu K; Uslu I
    Eur J Nucl Med Mol Imaging; 2008 Mar; 35(3):686. PubMed ID: 18071699
    [No Abstract]   [Full Text] [Related]  

  • 6. Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors.
    Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2009 Mar; 45(3):218-24. PubMed ID: 18804404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDG PET/CT in Monitoring Antituberculosis Therapy in Patient With Widespread Skeletal Tuberculosis.
    Hu N; Tan Y; Cheng Z; Hao Z; Wang Y
    Clin Nucl Med; 2015 Nov; 40(11):919-21. PubMed ID: 26284767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical disseminated skeletal tuberculosis mimicking metastasis on PET-CT and MRI.
    Go SW; Lee HY; Lim CH; Jee WH; Wang YP; Yoo IeR; Kang JY
    Intern Med; 2012; 51(20):2961-5. PubMed ID: 23064577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone metastasis versus bone marrow metastasis? Integration of diagnosis by (18)F-fluorodeoxyglucose positron emission/computed tomography in advanced malignancy with super bone scan: two case reports and literature review.
    Lin CY; Chen YW; Chang CC; Yang WC; Huang CJ; Hou MF
    Kaohsiung J Med Sci; 2013 Apr; 29(4):229-33. PubMed ID: 23541269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [FGD PET in a patient with pseudofractures from osteomalacia].
    Sánchez Salmón A; Núñez R; Yeung H; Healey J; Macapinlac H
    Rev Esp Med Nucl; 2002 Feb; 21(1):34-5. PubMed ID: 11821000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison and discrepancy of 18F-2-deoxyglucose positron emission tomography and Tc-99m MDP bone scan to detect bone metastases.
    Kao CH; Hsieh JF; Tsai SC; Ho YJ; Yen RF
    Anticancer Res; 2000; 20(3B):2189-92. PubMed ID: 10928175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disseminated osteomyelitis or bone metastases of breast cancer: (18)F-FDG-PET/CT helps unravel an unusual presentation.
    Mandegaran R; Debard A; Alvarez M; Marchou B; Massip P; Wagner T
    Ann Nucl Med; 2014 Feb; 28(2):167-71. PubMed ID: 24203488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of bone metastases in breast cancer patients in the PET/CT era: Do we still need the bone scan?
    Caglar M; Kupik O; Karabulut E; Høilund-Carlsen PF
    Rev Esp Med Nucl Imagen Mol; 2016; 35(1):3-11. PubMed ID: 26514321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and (99m)Tc-MDP whole-body bone scanning for imaging osteolytic bone metastases.
    Zhang L; Chen L; Xie Q; Zhang Y; Cheng L; Li H; Wang J
    BMC Med Imaging; 2015 Mar; 15():7. PubMed ID: 25885599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of whole body positron emission tomography/computed tomography scan with 18F-fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknown primary site.
    Pelosi E; Pennone M; Deandreis D; Douroukas A; Mancini M; Bisi G
    Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):15-22. PubMed ID: 16557200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculous synovitis of the hip joint diagnosed by FDG PET-CT.
    Makis W; Abikhzer G; Stern J
    Clin Nucl Med; 2009 Jul; 34(7):431-2. PubMed ID: 19542947
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pseudotumor of the rib].
    Benouachane T; Msefer Alaoui F
    Rev Mal Respir; 1999 Sep; 16(4):567-8. PubMed ID: 10549070
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of 18F-FDG PET/CT scan and 99mTc-MDP bone scintigraphy in detecting bone metastasis in head and neck tumors.
    Al-Bulushi NK; Abouzied ME
    Nucl Med Commun; 2016 Jun; 37(6):583-8. PubMed ID: 26813992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Stepwise Approach to Identify the Clinical Role of 18F-FDG PET/CT in Patients With Suspicious Bone Metastasis From an Unknown Primary Site.
    Chowdhury MSA; Jeon S; Bom HS; Min JJ; Kwon SY
    Clin Nucl Med; 2019 Sep; 44(9):e524-e525. PubMed ID: 31274555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDG-PET and CT patterns of bone metastases and their relationship to previously administered anti-cancer therapy.
    Israel O; Goldberg A; Nachtigal A; Militianu D; Bar-Shalom R; Keidar Z; Fogelman I
    Eur J Nucl Med Mol Imaging; 2006 Nov; 33(11):1280-4. PubMed ID: 16791597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.